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ABSTRACT

An abstract of the thesis of Zhidong Lu for the Master of Science in Biology
presented on July 9, 1997.

Title: Ovarian steroid regulation of tryptophan hydroxy lase enzyme level in the
,,.

midbrain raphe in ovariectomized guinea pigs.

Progesterone stimulates prolactin secretion in estrogen (estradiol-17-~)
primed monkeys and guinea pigs. It is hypothesized that the serotonin neural system
plays a pivotol role in mediating the effect of progesterone on prolactin secretion.
Indeed, progesterone, but not estrogen, increases serotonin levels in the midbrain
raphe in guinea pigs. However, estrogen alone stimulates gene expression of the
rate-limiting enzyme for serotonin synthesis, tryptophan hydroxylase (TPH), and
progesterone supplement to the estrogen regimen has no additive effect, as indicated
by TPH mRNA levels in monkeys. The discrepancy between ovarian steroid effects
on the TPH mRNA level and the serotonin level might be due to actions of
progesterone on post-transcripitonal processing of the TPH gene. In this
experiment, TPH protein levels were measured in the midbrain raphe in guinea pigs.
Guinea pigs were ovariectomized (OVX; n=5), estrogen-treated (28 d; n=6), and
estrogen plus progesterone-treated (14 d of estrogen and 14 day of estrogen plus
progesterone; n=5). Western analysis by chemiluminescence with densitometric
analysis was performed to detect and measure TPH protein levels. Hypothalamic
levels of neurotransmitters were also measured with high performance liquid
chromatography. The results showed that estrogen increased the TPH protein level

2
significantly compared to the OVX group (p<0.05). TPH protein level in the
estrogen plus progesterone-treated group was also significantly higher than in the
OVX group (p<0.05). However, there was no difference between estrogen- and
estrogen plus progesterone-treated guinea pigs. The hypothalamic 5-HT level was
significantly increased by estrogen plus progesterone treatment (p<0.05), but not by
estrogen alone. Thus, there continues to be a discrepancy between ovarian steroid
effects on the mass of TPH enzyme and on the serotonin level. Progesterone
increased the ratio of dopamine/homovanillic acid, suggesting that progesterone
might decrease monoamine oxidase, the degradation enzyme for both dopamine and
serotonin. In summary, progestrone did not increase prolactin secretion in estrogenprimed guinea pigs by regulating the post-transcriptional processing of the TPH
gene. It is possible that progesterone increases serotonin by increasing the activity
of TPH.
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1.

INTRODUCTION

Prolactin is a versatile hormone [1-4]. The number of the physiological
functions of prolactin exceeds 80 across the vertebrate phyla [5]. The preparation,
maintenance, and secretory activity of the mammary gland during lactation is
controlled by prolactin [2]. Therefore, prolactin is critical to the offspring of
mammalian species for survival. Also, prolactin plays a role in other physiological
processes including stimulation of the immune system [6,7] and responses to stress
[8,9].
Prolactin is primarily synthesized by lactotropes in the anterior pituitary.
Pituitary prolactin secretion is represented by serum prolactin levels. Prolactin
secretion fluctuates with ovarian steroids during the menstrual cycle and pregnancy
[ 10-13]. Lactotrope hypertrophy and pituitary enlargement occur at the end of
human and non-human primate gestation [14]. These observations suggest that
ovarian hormones, estrogen (estradiol-17-~) and progesterone, regulate prolactin
secretion. Indeed, progesterone has a stimulatory effect on prolactin secretion in
estrogen-primed monkeys [15] and guinea pigs [16]. Intriguingly, neither
progesterone nor estrogen alone have this effect [ 15-18].
The target cells of steroid hormones are defined by the presence of nuclear
receptors for the cognate hormones. The observation that pituitary lactotropes lack
progestin receptors [19-21] directed investigators to search for progesterone target
neurons in central nervous system (CNS). Among the neuroendocrine systems in
the hypothalamus and midbrain, serotonin neurons have been of special interest.
In rodents, serotonin enhances prolactin secretion [22]. Also in rodents,
progesterone increases the serotonin content of the raphe [ 16] as well as the
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hypothalamic serotonin turnover [23,24]. Double immunocytochemistry analysis
revealed that serotonin neurons in the dorsal and ventral raphe in the midbrain
contain progestin receptors [25], indicating that serotonin neurons are a target
system of progesterone. Furthermore, progestin receptors in this area are
maintained with estrogen plus progesterone treatment in a manner consistent with
the observation that progesterone induces prolactin secretion [26]. Hence,
serotonin may transduce the action of progesterone on prolactin secretion.
Therefore, it is of interest to know what are the cellular and molecular mechanisms
of the action of progesterone in serotonin neurons.
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2. REVIEW OF LITERATURE

2.1 Anatomy of Serotonin Neurons
Serotonergic neurons are a population of morphologically heterogeneous
cells located mainly in the brainstem [27-37]. These neurons are multipolar cells
with different sizes and orientations in different locations in the brainstem. The
raphe nuclei of the brainstem are the sites for the cell bodies of the majority of
serotonin neurons. Whereas the cells located in the midline regions of the raphe
nuclei are small to medium-size, and are oriented with most of their dendrites along
the mid-sagittal plane, cells distant from the midline are larger than those in the
midline regions [38]. Besides the raphe nuclei, the reticular formation is another
location containing serotonergic neurons. The reticular formation is peripheral to
the raphe nuclei, occupying the rostral and caudal ventrolateral medulla. The two
prominent nuclei in the midbrain raphe are the dorsal raphe nucleus, which is
located in the ventral part of the periventricular gray matter of the midbrain, and the
median raphe nucleus, which is on the midline and adjacent to the outside of the
midline in the brainstem [39,40].

2.2 Innervations and Projections of Serotonin Neurons
The raphe nuclei receive input from dopaminergic neurons in the substantia
nigra and ventral tegmental area, acetylcholinergic neurons in the superior vestibular
nucleus, norepinephrinergic neurons in locus coeruleus, and epinephrinergic
neurons in the nucleus prepositus hypoglossi and the nucleus of the solitary tract
[41]. There are also afferent innervations of serotonin neurons from the
hypothalamus, thalamus, and limbic forebrain structures.
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The high degree of polarity of the serotonergic projections is a unique
feature of the serotonergic system [42-44]. The serotonin cells consist of two
distinct groups, a caudal group in the medulla oblongata and in the caudal half of
the pons, and a rostral group in the midbrain and rostral pons. Both the dorsal
raphe nucleus and the median raphe nucleus belong to the rostral serotonergic
system. Serotonin neurons send axons from the rostral group towards the
forebrain and from the caudal system to the structures of the brainstem and to the
spinal cord.
The ascending projections of the rostral serotonergic system are very
extensive and contain many collaterals innervating diverse regions of the cerebral
cortex, basal ganglia, limbic system and diencephlon [31,37,42,45-49]. Two main
pathways for these rostral projections are the dorsal periventricular path and the
ventral tegmental radiations. Both pathways converge in the caudal hypothalamus
where they join the medial forebrain bundle. From the medial forebrain bundle,
distinct sets of axons from different raphe nuclei diverge to form different subpathways which they follow to their target areas in the brain. All areas of the
forebrain display specific innervations. Functionally related structures are
innervated by the same set of serotonin neurons [50,51].
The hypothalamus receives extensive innervation from serotonin neurons
[52,53]. Neurons innervating the hypothalamus are primarily from the dorsal and
median raphe nuclei. The pathways of the projections of these neurons are the
medial forebrain bundle, a dorsal raphe arcuate tract, and a dorsal raphe
periventricular tract [53]. The arcuate nucleus has dense serotonergic innervations
[27-29]. In the arcuate nucleus and in the medial zona incerta, dopamine neurons
which project to the hypothalamus juxtapose with serotonin-containing fibers
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[54,55]. These serotonin and dopamine interactions support the hypothesis that
serotonin plays a role in the regulation of prolactin release via inhibition of TIDA
neurons [22].

2.3 Release of Serotonin
Serotonin neurons store serotonin in vesicles and release the
neurotransmitter by exocytosis. Serotonin released into the synapse binds with
specialized serotonin membrane receptors and carries out actions in target tissues.
There are several mechanisms to regulate serotonin secretion and function. The
initial step in the synthesis of serotonin is the facilitated transport of the amino acid
L-tryptophan in dietary protein from the circulation to the brain. Clinical studies
show that the availability of the amino acid transporters and the concentration of
tryptophan in the blood influence serotonin content in the brain [56]. Tryptophan
hydroxylase (TPH; EC 1.12.16.4) is the rate-limiting enzyme for serotonin
synthesis [41]. The fluctuation of TPH content and activity should cause
consequent changes in serotonin content in the brain. Second, the degradation of
serotonin influences the content of serotonin in the brain. Monoamine oxidase
(MAO) (EC 1.4.3.4) converts serotonin into 5-hydroxyindoleacetaldehyde, which
is oxidized to form 5-hydroxyindoleacetic acid (5-HIAA), the primary metabolite of
serotonin. Usually, serotonin is protected by the membranes of the storage vesicles
from degradation by MAO and serotonergic neurons do not contain much MAO.
However, clorgyline, an inhibitor of a type A MAO, increases serotonin levels and
reduces the conversion of serotonin to 5-HIAA in the brain [57]. Third, the
removal of serotonin from the synapses would affect serotonin neurotransmission.
Serotonin reuptake transporters (SERT) remove serotonin from the synapse and

6
terminate the activity of serotonin. Fourth, different subtypes of serotonin
receptors and different densities of these subtypes mediate different effects of
serotonin. Not only are the subtypes of serotonin receptors coupled to different
signal transduction mechanisms, they also have different distribution patterns in the
brain. Serotonin1A receptors down-regulate serotonin activity when they function
as autoreceptors [58]. However, serotonin lA can be located post-synaptically as
well.

2.4 Functions of Serotonin
Serotonin has many important and diverse physiological actions. Serotonin
has beeen implicated in sleep and arousal states [59]. Serotonin also appears to
play a role in the regulation of circadian rhythms [60,61]. The SCN, the biological
clock nuclei, receive dense serotonin innervation from the midbrain raphe nuclei.
Observations suggest serotonin inhibits food intake [62]. Serotonin deficiency has
beeen related to depression and most major mood disorders [63]. Serotonin in the
pineal gland is the precursor of melatonin, a hormone related to the seasonal
breeding cycles of sheep and hamsters. Serotonin is also among the many
neurotransmitters that participate in the hypothalamic control of the pituitary
secretion, particularly in the regulation of adrenocorticotropin, growth hormone and
prolactin [22].

2.5 Effects of Steroids on Serotonin

Some studies suggest that serotonin participates in the regulation of
physiological processes that are dependent upon or sensitive to steroid hormones,
such as ovulation [64], sexual behavior [65], and the response to stress [66].
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However, information on the effects of steroids on serotonin activity is scant and
the molecular mechanism for these effects are unresolved.

2.5.1 Corticosteroids
Stress increases the activity of the hypothalamic-pituitary-adrenal axis and
causes an elevation in glucocorticoid secretion [67]. The activity of TPH, the ratelimiting enzyme in serotonin synthesis, is affected by adrenalectomy [68] and
glucocorticoids [69] in rats. Adrenalectomy also decreases serotonin reuptake into
hypothalamic terminal neurons. Plasma corticosterone is inversely correlated with
serotonin content in the amygdala and directly correlated with hypothalamic
serotonin content [70]. In the hypothalamus, adrenalectomy decreases serotonin
turnover in some nuclei while the supraoptic nucleus exhibits a large increase.
Corticosterone treatment partially reverses these effects [71 ]. Serotonin 1 receptors
in the dorsal raphe but not in the median raphe are increased following
adrenalectomy [72]. Corticosterone replacement reverses the effects.

2.5.2 Gonadal Steroids

The ovarian steroids, estrogen and progesterone, are produced in a cyclic
manner throughout the estrous and menstrual cycles. Administration of estrogen
and progesterone results in time-, dose- and region-specific changes in serotonin
reuptake in rats[73-75]. In the dorsal raphe nucleus, estrogen in rats [76-77] and
estrogen plus progesterone in guinea pigs [ 16] increase serotonin levels.
Hypothalamic serotonin turnover increases with estrogen plus progesterone
treatment, but not with estrogen alone [78,79]. In addition, progesterone partially
blocks the effect of p-chorophenylalanine (PCPA), a serotonin synthesis inhibitor,
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on hypothalamic serotonin levels and an antiprogesterone reduced hypothalamic
levels of 5-HIAA, a serotonin metabolite [78]. Moreover, PCPA inhibits the
proestrus surge of prolactin and progesterone treatment reverses this effect [80].
Progesterone could also affect the levels of serotonin receptor expression in
target neurons. Serotonin2 receptors are stimulatory, post-synaptic receptors which
act through the phosphoinositol pathway [81,82] whereas serotonin IA receptors
may be pre- or post-synaptic [83]. As autoreceptors, serotonin I receptors inhibit
the activity of serotonin neurons. In vivo treatment with estrogen displays a
biphasic effect on the density of serotonin 1 receptors in the rat brain [85]: an
increase in the receptor density followed by a sudden decrease 48 hours later.
Prolonged treatment with estrogen or progesterone induces a down regulation in
serotonin} receptors, whereas the number of serotonin2 receptor goes up [84,85].
Progesterone administration to estrogen-treated rats reverses the estrogen-induced
increase in serotonin2 receptors, but has no effect on the estrogen-induced
reduction in serotonin 1 receptors.

2.6 Role of Serotonin in Prolactin Secretion
Although serotonin does not act directly at the pituitary to release prolactin
[86], a pivotal role for serotonin in prolactin secretion is well-supported [22-24].
Many pharmacological studies have shown a stimulatory effect of serotonin on
prolactin secretion in rodents. The serotonin precursor, 5-hydroxytryptophan,
alone or with fluoxetine (a serotonin reuptake inhibitor) stimulated prolactin
secretion [23]. In addition, serotonin antagonists for serotonin1B receptors block
the stimulating effects of fenfluramine, a serotonin releaser [23], or serotonin
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agonists [24] on prolactin secretion. However, the cellular and molecular action of
progesterone in serotonin neurons is unknown.

2. 7 Guinea Pig Model
The majority of the studies on the regulation of serotonin by estrogen and
progesterone are performed with rats. However, rats differ significantly from
primates and humans in the regulation of prolactin secretion by ovarian steroids
[13,15,87]. Another small laboratory animal model would be beneficial to elucidate
the cellular and molecular consequences of ovarian steroid actions in serotonin
neurons.

2. 7.1 Guinea Pig Physiology
Guinea pigs have a 16- to 18-day estrous cycle with the length of estrus to
be 8.21 ± 0.07 hours [88]. Ovulation occurs approximately IO hours following the
onset of estrus and usually within 1.5 to 2 hours of the end of estrus [88-90].
Unlike rats, but similar to primates, guinea pigs exhibit prolonged function
of the corpus luteum and elevated progesterone secretion after ovulation [91]. The
gonadotropins, estrogen and progesterone have been examined throughout the
guinea pig estrous cycle [92] and during pregnancy [91]. Also in guinea pigs,
ovarian steroids regulate prolactin secretion in the same manner as ovarian steroids
do in primates. That is progesterone, in addition to estrogen, but not estrogen
alone, increases serum prolactin in OVX guinea pigs [16] and monkeys [15,17,18].
Thus, guinea pigs may provide a better model for non-human primates than rats for
studies of the neural mechanism mediating the effects of ovarian steroids on
serotonin and prolactin.
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2. 7.2 Previous Reports on Steroid Regulation of Serotonin and Prolactin in
Guinea Pigs
Guinea pigs were OVX, estrogen-treated (28 days) and estrogen plus
progesterone-treated ( 14-day estrogen with 14-day estrogen plus progesterone)
[ 16]. Serotonin was measured in the midbrain rap he area by high performance
liquid chromatography (HPLC). Serum prolactin was measured with the NB2
lymphoma bioassay. Estrogen alone had little effect on serum prolactin levels, but
estrogen plus progesterone significantly increased prolactin compared to the OVX
controls. Serotonin levels were similar in OVX and estrogen-treated groups.
Addition of progesterone to the estrogen treatment significantly increased serotonin
compared to the estrogen-only treatment. Thus, the pattern of the steroid regulation
of serotonin levels in midbrain raphe is consistent with that of the steroid regulation
of serum prolactin in guinea pigs, which in tum, is consistent with the effect of
estrogen and progesterone on prolactin secretion in monkeys. Hence, guinea pigs
are an appropriate model in which to determine the mechanism by which
progesterone increases serotonin in the dorsal raphe.

2.8 Statement of Purpose
Steroids penetrate the blood brain barrier easily and interact with nuclear
receptors in target neurons [93,94]. The steroid hormone-receptor complexes are
transcription factors for gene expression. Serotonin neurons in monkeys contain
progestin receptors [25] and the expression of progestin receptors is under the
regulation of estrogen and progesterone [26], indicating that progesterone acts in
serotonin neurons. Pecins-Thompson et al. showed that estrogen increased TPH
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mRNA in monkeys but progesterone had no additive effect [95]. However, in
guinea pigs, estrogen plus progesterone but not estrogen alone increased serotonin
content in the raphe [16]. The discrepancy between TPH mRNA levels in monkeys
and serotonin levels in guinea pigs suggested that pregesterone may affect posttranscriptional events to modify TPH function. It was also possible that a species
difference between guinea pigs and monkeys was involved. Since previous studies
had measured serotonin in the midbrain raphe in guinea pigs, this study examined
the effects of estrogen and progesterone on TPH protein levels in the raphe nuclei
and correlated the TPH protein concentrations in the raphe nuclei with the
hypothalamic serotonin concentration in guinea pigs.
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3. MATERIALS AND METHODS

3.1 Animals and Experimental Groups
All animals were euthanized according to procedures recommended by the
Panel on Euthanasia of the American Veterinary Medical Association. These
experiments were approved by the Oregon Regional Primate Research Center
Animal Care and Use Committee.
All animal treatments and brain tissue harvest procedures are according to
the procedures by Bethea et al. [16]. Sixteen adult OVX guinea pigs were
purchased from Charles River Laboratories (Wilmington, Mass., USA). Guinea
pigs were housed in individual cages in a temperature- and light- (12 h light/12 h
dark) controlled room. They were fed Purina guinea pig chow, and water was
available at all times. Green vegetables were supplied every other day.

3.2 Surgery and Treatments
Two weeks following OVX, the guinea pigs were weighed and injected
with a guinea pig anesthetic consisting of 50 mg/kg ketamine HCl (Mallinckrodt
Veterinary Inc., Mundelein, IL), 1 mg/kg Acepromazine Maleate (Bums Veterinary
Supply, Rockville Center, NY), and 2 mg/kg Rompun (Miles Inc., Shawnee
Mission, KS) for insertion of Silastic capsules (0.5 cm long; inner diameter 0.062
in, outer diameter 0.125 in; Dow Coming, Midland, Ml) which were either empty
(n=4) or filled with crystalline estradiol (n=8;

1,3,5,(1O)-Estratrien-3,17-~-Diol,

Steraloids, Wilton, NH). The capsule was placed in the periscapular area.
Incisions were 1 cm long and sutured or woundclipped after Silastic capsules were
placed subcutaneously. Fourteen days later, half of the estrogen-treated guinea pigs
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were sedated for insertion of Silastic capsules ( 1.5 cm long) filled with crystalline
progesterone (n=4; 4-pregnen-3,20 Dione, Steraloids). Fourteen days later, the
animals were injected with the guinea pig anesthetic and decapitated in sets
containing an OVX, an estrogen-treated, and an estrogen plus progesterone-treated
animal. Vaginal smears were obtained prior to decaptation. Trunk blood was
collected for determinations of serum estrogen and progesterone levels by RIA.
The brains were immediately dissected. The hypothalamus and midbrain were
weighed and the hypothalamic block was dropped into liquid nitrogen for later
microdissection and measurement of serotonin and 5-HIAA. The raphe block was
immediately homogenized for measurement of TPH enzyme. The wet weight of the
pituitary was obtained following removal of the brain from the skull. The same
experiments were repeated on an additional set of OVX (n= 1), estrogen- (n=2), and
estrogen plus progesterone-treated (n=l) animals one month after OVX.

3.3 Midbrain Harvest
The pontine midbrain section (approximately 3 mm thick) displayed the
rounded central canal on its anterior surface and the wing-shaped canal on its caudal
surface. This section was microdissected immediately at necropsy and a small
square piece of tissue was harvested which extended from the top of the central
gray to the decussation of the cerebellar peduncles. The piece was the width of the
central gray and contained the major portion of the dorsal raphe. Each piece was
immediately homogenized in 250 ml of 50 mM Tris (pH 7.5; ICN Biomedicals,
Aurora, OH) and 20 mM 2-~-mercaptoethanol (Sigma Chemical Co., St. Louis,
MO) and centrifuged at 10,000 x g for 2 minutes. The supernatant was removed
and stored at -80 ° C until TPH western analysis. The pellet was dissolved in 0.5
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N NaOH by boiling for 15 min. Protein assays were performed on both the
supernatant and the dissolved pellet.

3.4 Hypothalamic Harvest
Hypothalamic blocks were obtained from each animal. Each block is
bordered by optic chiasm, mamillary bodies, and lateral sulci. The block was
wrapped in foil and dropped in liquid nitrogen at necropsy, then stored at -80 ° C
until HPLC analysis. Immediately prior to analysis, each hypothalamic block was
slightly thawed and the rostral one-third of the block was dissected out and
discarded. The medial part, containing the dorsal medial hypothalamus (DMH),
and the mediobasal hypothalamus (MBH), was trimmed on the sides, vertical to the
innermost border of the optic tract and horizontal to the caudal tip of the third
ventricle. DMH contained the majority of the dorsomedial nuclei and the caudal end
of the paraventricular nucleus whereas MBH contained ventromedial, ventrolateral,
and arcuate nucleus. There was no left-right division of blocks.
Each piece was homogenized in 1 ml of mobile phase ( 101 mM sodium
acetate trihydrate, Sigma; 67 mM citric acid monohydrate, Sigma; and 4%
Methanol, Baxter Healthcare Corporation) containing 1 pg/ul
dihydroxybenzylamine internal standard. The sample was centrifuged at
10,000 x g for 2 minutes, and the supernatant was removed and filtered through
Microcon-10 microconcentrators (Amicon Inc., BEverly, MA) for amine HPLC.
The pellet was resuspended in 1 ml of 0.5 N NaOH to determine protein levels.
Previous characterization has found that 95-98 % of the total protein is precipitated
by the mobile phase [16].
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3.5 Midbrain TPH Western Analysis
The protein content of the raphe supernatant was determined with the BioRad protein determination reagent according to the method of Bradford [96].
Raphe extracts containing 300 µg of protein were loaded on a 10% SDS
polyacrylamide gel. A monkey pineal extract containing 129 µg of protein was used
as a positive control. Western blotting was performed according the modified
procedures of Dumas et al. [97] with blotting buffer containing 25 mM Tris base
(ICN) and 192 mM glycine (Sigma). Nitrocellulose transfer membrane was from
Schleicher & Schuell (Keene, NH). The nitrocellulose membrane was blocked
with 5% aqueous Carnation natural non fat dry milk (Nestle Food Company,
Glendale, CA) for 45 minutes. Affinity purified sheep anti-TPH (Chemicon
International Inc., Temecula, CA) was used at a dilution of 1/500 in buffer
containing 50 mM Tris (Sigma) and 150 mM NaCl (Sigma) (pH 7.5). Rabbit antisheep antibody conjugated with horse radish peroxidase (Chemicon) was used as
second antibody at a dilution of 117 ,000. TPH signal was detected by exposing the
blot to chemiluminescent-sensitive film after developing with ECL detection
reagents (Amersham International Plc., Buckinghamshire, England) as described
by Brandon and Bethea [98].

Scientific imaging film (Eastman Kodak) was used

for diagnostic developing and the exposure time was 15 minutes. For the
quantitative analysis of TPH, the NIH image software program was used.

3.6 Assay Validation
The reliability of the quantitative analysis for TPH protein was confirmed by
analyzing increasing concentrations of monkey pineal gland protein extracts and
monkey raphe protein extracts. Five monkey pineals were homogenized with 0.5
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ml of buffer as above. The protein level was measured according to Bradford [96].
Pineal extract samples (50 µg, 100 µg, and 150 µg of protein) were
electrophoresed and blotted as described above and used for quantitative analysis of
TPH. One monkey raphe was processed with the same method and extract samples
(100 µg, 200 µg, and 300 µg of protein) were electrophoresed and blotted as
described above and used for quantitative analysis of TPH.

3. 7 Densitometric Analysis of Western Blotting Results
The image of the TPH bands on the film were captured using a XC-77 CCD
video camera (Sony, Towada, Japan). The pineal TPH band was copied below the
TPH band from each sample. The region of interest containing the pineal band and
the sample band was marked. The image analysis program scanned each lane from
the top to the bottom and read the density of each band. The density of the TPH
band on the film was converted to a peak. The area under each peak was
calculated. The TPH band from monkey pineal extract was used as the positive
control. The image analysis program used the density of the positive control band
as the maximum reading on the scale for density reading.

3.8 HPLC for Monoarnines
The content of serotonin, 5-HIAA, dopamine, and homovanillic acid in the
hypothalamic block was determined by HPLC with electrochemical detection
(Waters). A Keystone (Keystone SCI. INC.) catecholamine column (ODS
Hupersil, 100 x 4.4 mm, 3 µm particle size ) was used with mobile phase as above
(see section 2.4). The eluent was passed through an electrochemical detector
(Waters 460) set at +0.60 V and 0.2 nA. The concentration of the calibration
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standard for biogenic amines was at 5 pg/µl. The average retention times for
dopamine, 5-HIAA, homovanillic acid, and serotonin were 7.0, 9.7, 15.1, and
22.0 minutes respectively. The sensitivity of detection was 10 pg for dopamine,
5-HIAA, and serotonin and 50 pg for homovanillic acid. The concentrations of
monoamines were quantitated by comparing the area under the peak of the
unknown sample with the peak area of a standard. Standard preparations were
analyzed at increasing injection volumes, and the measurement of dopamine,
5-HIAA, and serotonin was linear between 10 and 500 pg, and linear between 50
and 500 pg for homovanillic acid. The unknown samples were assayed at 5 µl for
dopamine, 5-HIAA, and serotonin and at 100 µl for homovanillic acid which fell
within the linear range for each amine. Amine levels were normalized to nanograms
per milligram protein.

3.9 Protein Assay
Protein content in both raphe and hyphothalamus tissues was measured
according to Bradford using Bio-Rad protein determination reagent [96].

3.10 Estrogen and Progesterone R!As
The estradiol-17-~ and progesterone levels were determined with RIA as
described by Resko et al. [99, 100].

3.11 Statistical Analysis
Midbrain TPH protein levels, hypothalamic monoamine concentrations,
pituitary wet weight, serum estrogen and progesterone, brain wet weight, and
protein content were compared using analysis of variance (ANOV A) followed by
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the Student-Newman-Keuls pairwise post-hoc comparison. Data analysis was
conducted using the Instat Statistic Program (GraphPad, San Diego, CA) on a
Macintosh computer. A confidence level of p < 0.05 was considered significant.

3.12 Vaginal Smears
Prior to necropsy, vaginal smears were obtained from all animals with
saline lavage. The lavage was placed on microscope slides (Fisher Scientific,
Auburn, WA). Smears were then air-dried overnight and stained with hematoxylin
(Sigma) for 5 minutes. Sections were then dehydrated in a graded series of
alcohol, and coverslipped with Permount. Vaginal smears from different treatment
groups were compared as a confirmation of steroid treatment.
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4.

RESULTS

4.1 Assay Validation for Quantitative Analysis ofTPH Enzyme
The densities of the TPH enzyme signals from the western analysis are
positively correlated with the concentrations of the protein (Figure 1). The density
(peak area) of 50, 100, and 150 µg of pineal TPH protein extracts was 596, 2243,
and 3369, respectively. The density (peak area) of 100, 200, 300 µg of raphe
protein extracts was 3399, 5395, and 9102, respectively. The quantitative analysis
of TPH enzyme with Western analysis and the NIH Image Analysis software was
linear in the range of 50 to 300 µg of protein.

4.2 Western Analysis of TPH Enzyme in Steroid-treated Guinea Pigs
The results of western blot analysis of the 16 guinea pigs are shown in
Figure 2. The film (Panel B) was compared with the nitrocellulose membrane
(Panel A) stained with 2% Ponceau-S (Sigma), demonstrating the specificity of the
western analysis. The Ponceau-S-stained nitrocellulose membrane displayed
multiple protein bands. However, the affinity-purified anti-TPH antibody
specifically binds to TPH enzyme. Thus, TPH signals were shown by the single
band in each lane of panel B after ECL chemilumenescence. For densitometric
anaylysis, the monkey pineal TPH band, as a positive control, was placed below
each sample band as shown in Figure 3. The pineal band enabled the computer to
accurately scale each lane the same. Two representative plots from the
denstiometric analysis are shown in Figure 4.
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4.3 Midbrain Raphe TPH Content
The results on TPH enzyme levels are shown in Figure 5. Average TPH
content (peak area ± SEM) was 1636.40 ± 252.66, 2836.67 ± 132.38, and
2515.00 ± 326.79 for the OVX, estrogen-treated, and estrogen plus progesteronetreated groups, respectively (Fig 5.A.). TPH enzyme level (ratio of the reading
from each sample band over the reading from the pineal control band ± SEM) was
0.397 ± 0.063, 0.738 ± 0.039, and 0.676 ± 0.086 for the OVX, estrogen-treated
and estrogen plus progesterone-treated guinea pigs, respectively (Figure 5.B.). In
the raphe, estrogen treatment approximately doubled the TPH enzyme level
(p < 0.05). Addition of progesterone did not change the TPH enzyme levels
compared to estrogen-only treatment. However, the level of TPH enzyme in the
estrogen plus progesterone-treated group remained significantly higher than that in
the OVX group (p < 0.05). Thus, TPH protein in estrogen-treated and estrogen
plus progesterone-treated groups was significantly higher than that in the OVX
group, but estrogen- and estrogen plus progesterone-treated groups were not
different from one another.

4.4 Assay Validation for HPLC Measurement of Biogenic Amines in the
Hypothalamus
The concentration of the standard biogenic amines for calibration was at
5.0 pg/µl in 0.07 mM sodium acetate (Sigma). Volumes of the calibration solution
injected in HPLC were 2, 5, 10, 50, 100 µI. The amine concentrations were
converted from peak areas as shown in the chromatograms (Figure 6, A and B).
Peak responses for serotonin, 5-HIAA, and dopamine were linear within the range

21
of 10 and 500 pg (Figure 6, C and D). The peak responses for homovanillic acid
were linear within the range of 50 and 500 pg.

4.5 Concentrations of Biogenic Amines in the Hypothalamus
The average of the serotonin concentrations (ng/mg of protein, ±SEM) was
7.46 ± 0.77, 7.76 ± 0.70, and 10.08 ± 0.50 for the OVX, estrogen, and estrogen
plus progesterone groups, respectively. Serotonin levels increased significantly in
the estrogen plus progesterone-treated group compared to estrogen-treated group
(p < 0.05;

Figur~

7.). There was no significant difference between estrogen-

treated group and OVX group in serotonin levels (p > 0.05; Figure 7). 5-HIAA,
dopamine, and homovanillic acid concentrations showed no differences among the
OVX, estrogen, and estrogen plus progesterone groups (p > 0.05) (Figure 7 and
8). However, the ratio of the concentration of dopamine over that of homovanillic
acid, had a significant increase in estrogen plus progesterone-treated group
compared to OVX (p < 0.05; Figure 9). The ratio of serotonin/5-HIAA had a
moderate but statistically insignificant increase in the estrogen plus progesteronetreated group compared to estrogen-treated and OVX group.

4.6 Pituitary Wet Weight
The average wet weight of the pituitary in each treatment group is shown in
Table 1 and Figure 10. The weight of the pituitary in the estrogen- and estrogen
plus progesterone-treated groups are significantly higher than that of the OVX
group (p < 0.05). Comparisons between the wet weight and the ratios of the wet
weight to the body weight maintain the same pattern.
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4. 7 Steroid Hormone Levels
The estrogen levels (pg/ml ± SEM) equaled 36.00 ± 2.65 in the OVX
guinea pigs and 141.82 ± 36.72 in the estrogen and estrogen plus progesterone
groups (p < 0.01 ). The progesterone levels (ng/ml ± SEM) averaged 0.10 ± 0.10,
0.05 ± 0.03, and 4.13 ± 0.36 in the OVX, estrogen, and estrogen plus
progesterone groups, respectively. Progesterone levels in the estrogen plus
progesterone group were significantly higher than that in the OVX and estrogen
groups (p < 0.001). The steroid replacement treatment changed the serum estrogen
and progesterone levels within or close to the physiological range [92] (Table 2.)

4.8 Vaginal Smears
Vaginal smears were taken before necropsy to verify the efficacy of steroid
implants. Representative pictures of the stained vaginal smears from OVX,
estrogen, and estrogen plus progesterone groups are shown in Figure 11. The
predominance of small leukocytes was the characteristic of the vaginal smears of
OVX group. Large numbers of comified squamous epithelial cells dominate the
vaginal smears of estrogen-treated group. The infiltration of small leukocytes and
the presence of round nucleated epithelial cells can be seen in the vaginal smears of
estrogen plus progesterone-treated guinea pigs.

4.9 Brain Section Wet Weight and Protein Content
The wet weight of dissected hypothalamic and raphe fragments were
consistent, indicating the dissection was reproducible. The total protein content in
the raphe blocks and in the hypothalamic blocks had little variance among different
treatment groups as well. The average weight (mg± SEM) of the raphe sections
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did not differ significantly between treatment groups (105.32 ± 5.73, 113.93 ±
8.58, and 102.48 ± 3.26 for the OVX, estrogen, and estrogen plus progesterone
groups, respectively; p > 0.05). The wet weight (mg ± SEM) of the hypothalamic
sections did not differ significantly between treatment groups ( 164.88 ± 20.42,
166.25 ± 14.50, and 172.40 ± 7 .89 for the OVX, estrogen, and estrogen plus
progesterone groups, respectively; p > 0.05). The ratio of the protein content to
the wet weight of each brain dissection were also consistent from group to group
(Table 3).
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Figure I. Assay validation for measurement of TPH protein. Increasing amounts of
pineal protein extracts and raphe protein extracts were processed with Western
analysis and densitometric measurement. The Western results are shown in Panel A.
Note with the increasing amounts of protein (in µg, shown above each lane), the
density of each band increases as indicated by a peak area (numbers below each
band). Panel B shows that the densitometric analysis of TPH protein is linear in the
range of 50 and 300 µg of protein.
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A.

B.

66,20

Figure 2. Western analysis results. A. Ponceau-S-stained nitrocellulose blot.
B. Film of the blot after incubation with anti-TPH antibody and ECL detection.
Note the multiple protein bands in each sample lane shown by Ponceau-S staining in
A and the specificity for TPH protein of the western analysis shown by a strong
signal band in each lane in B.
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ovx

E

EP

Figure 3. Densitometric analysis of the TPH protein levels. Monkey pineal (MP)
TPH band (the darker rectangular square at the lower part of each lane) was copied
under each sample band as a positive control. Lanes 2 through 6 represent the OVX
guinea pigs (n=5); lanes 7 through 12 represent the estrogen-treated group; lanes 13
through 17 represent the estrogen plus progesterone-treated group. Each labeled lane
was marked as a region of interest. Densitometric analysis was achieved by scanning
from the top to the bottom of each lane with the reading from the pineal band set as
the maximum value on the scale of density.
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Figure 4. Reading the denstity of TPH bands. A and B are peaks from two
representative TPH bands, one from an OVX guinea pig and the other from an
estrogen (E)-treated guinea pig. The calculated peak areas are shown in C and D.
The calculation requires sealing of the peak areas. Note the relative consistent
reading obtained on the positive control. p, the pineal TPH peak.
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Figure 5. TPH enzyme levels. A. Average TPH enzyme levels (peak area).
B. TPH enzyme (density of sample band/density of pineal control band) in the
midbrain raphe. Guinea pigs were OVX, estrogen (E)-treated (28 days), and
estrogen plus progesterone (EP)-treated ( 14-day of estrogen plus 14-day of estrogen
plus progesterone) as described in Materials and Methods. TPH enzyme levels were
significantly different between estrogen-treated and OVX groups. There was also a
significant difference on TPH levels between estrogen plus progesterone-treated and
OVX groups. Statistics was analyzed with ANOV A followed by Student-NewmannKeuls comparisons (*, p<0.05). The levels of TPH enzyme in estrogen- and
estrogen plus progesterone-treated groups were similar.
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Figure 6. HPLC for biogenic amines . Two representative chromatograms:
A. OVX guinea pig. B. Estrogen plus progestin-treated guinea pig. Average
retention times for dopamine, 5-HIAA, homovanillic acid, and serotonin (5-HT)
were 7.0, 9.7, 15.1, and 22.0 minutes, respectively. Concentrations of biogenic
amines in samples were determined by comparing the peak areas of samples with the
peak areas of amine standards (not shown) on chromatograms. Amine standards for
calibration ranged from 10 to 500 pg and the peak response was linear throughout the
range for serotonin (C), 5-HIAA (D), and dopamine (not shown). Peak response for
homovanillic acid was linear in the range of 50 and 500 pg (not shown).
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Figure 7. Hypothalamic serotonin (5-HT) and 5-HIAA levels (ng/mg of
protein±SEM). Guinea pigs were OVX, estrogen (E)-treated (28 days), and
estrogen plus progesterone (EP)-treated ( 14-day of estrogen and 14-day of estrogen
plus progesterone). There was a significant increase in the serotonin level in
estrogen plus progesterone-treated group compared to the estrogen-treated groups
(*, p < 0.05; ANOVA followed by Student-Newmann-Keuls comparisons). There
was no difference in serotonin levels between estrogen-treated and OVX group. 5HIAA levels did not show any differences between treatment groups.

31

20-i

-15
C>

-E
C>
c
~

c
E

I

I

I

•

D

DA

~ HVA

10

<(

5

o-......_-

ovx

E

EP

Figure 8. Hypothalamic dopamine (DA) and homovanillic acid (HV A) levels (ng/mg
of protein± SEM). Guinea pigs were OVX, estrogen (E)-treated (28 days), and
estrogen plus progesterone (EP)-treated ( 14-day of estrogen and 14-day of estrogen
plus progesterone). There were no significant differences between treatment groups
(p > 0.05; ANOV A and Student-Newmann-Keuls comparisons).
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Figure 9. Ratios of serotonin over 5-HIAA (5-HT/5-HIAA) and dopamine over
homovanillic acid (DA/HV A) (±SEM). Guinea pigs were OVX, estrogen (E)-treated
(28 days), and estrogen plus progesterone (EP)-treated (14-day of estrogen and 14day of estrogen plus progesterone). There was a significant increase of DA/HV A in
estrogen plus progesterone-treated group versus OVX group (*, p < 0.05). There
was no difference between estrogen-treated group and OVX group on DA/HV A.
The modest increase of 5-HT/5-HIAA in estrogen plus progesterone-treated group
was not statistically significant compared to estrogen-treated and OVX groups.

33

16

*

14
,-....

12

bl)

8

'-'

......

10

<!)

8

...c
bl)

··-B
~

::>...
lo-<

~
......

~

6
4

2
0

I

ovx

E

EP

Figure 10. Pituitary wet weight in steroid-treated guinea pigs. Guinea pigs were
OVX, estrogen (E)-treated (28 days), and estrogen plus progesterone (EP)-treated
(14-day of estrogen and 14-day of estrogen plus progesterone). The average weight
of the pituitary glands of estrogen-treated and estrogen plus progesterone-treated
groups are significantly higher than that of the OVX group (*, p<0.05).
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Figure 11. Vaginal smears of steroid-treated guinea pigs. (A) Small leukocytes
predominate in the vaginal smears of OVX guinea pigs (thin arrow). B: In estrogentreated guinea pigs, large numbers of comified squamous epithelial cells are often in
clusters (white arrow) C: The infiltration of small leukocytes is the main
characteristic of the vaginal smears of estrogen plus progesterone-treated guinea
pigs. A few epithelial cells with visible nucleus appear occasionally (solid thick
arrow).
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Table 1. Pituitary wet weight (± SEM) after 28 d of steroid treatment.
Treatment

Pituitary Wet Weight The Ratio of Pituitary
(mg)
Weight over Guinea
Pig Body weight
(mg/g)

OVX (n=5)

10.34 ± 1.42

0.019 ± 0.0014

E (n=6)

14.18 ± 0.46**

0.027 ± 0. 0014***

EP (n=5)

13.48 ± 0.76**

0.025 ± 0.0012**

** significantly different from OVX (p < 0.05); *** significantly
different from OVX group(p < 0.01). E, estrogen-treated group; EP, estrogen plus
progesterone-treated group.
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Table 2. Serum estrogen and progesterone levels (± SEM) after 28 d of steroid
treatment.
Treatment

Estrogen (pg/ml)

Progesterone (ng/ml)

ovx

36.00 ± 2.65
(n=3)

0.10 ± 0.10
(n=5)

E
141.82 ± 36.72**
(n= 11)

0.05 ± 0. 03
(n=6)

4.13 ± 0.36***
(n=5)
**significantly different from OVX (p < 0.01); ***significantly
different from OVX and E-treated group(p < 0.001). E, estrogen-treated group;
EP, estrogen plus progesterone-treated group.

EP
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Table 3. Wet weight (mg± SEM) and protein content (µg ± SEM) of raphe and
hypothalamus dissections.

I ovx

Dissection

(n=5)

Raphe Wet Weight

I 105.32

E
(n=6)

ns

3221.00
± 272.01

ns

56.12
± 4.87

48.02
± 2.86

ns

0.21
± 0.02

0.20
± 0.02

0.19
± 0.01

ns

1164.88
± 20.42

166.25
± 14.50

172.4
± 7.89

ns

113.93
± 8.58

Raphe Protein Conten13059.00 3709.17
± 260.83 ± 362.91

I

Ratio of Raphe Total
Protein Content I
Raphe Wet Weight
Ratio of Raphe Wet
Weight I Guinea Pig
Body Weight
Hypothalamus Wet
Weight

47.26
± 2.36

I

Hypothalamus Protein 2860.40 3474.17 ± 3066.80
Content
± 334.00 237.05
± 466.10

I

Hypothalamus Ratio of
17.71
Hypothalamus Protein ± 1.66
Content/
Hypothalamus Wet
Weight
Ratio of
Hypothalamus Wet
Weight I Guinea Pig

ANOVA

102.48
± 3.26

± 5.73

Rap he

EP
(n=5)

I

o.32
± 0.05

ns

21.42
± 1.87

18.35
± 3.43

ns

0.32
± 0.04

0.32
± 0.01

ns

I Bod~ Wei~ht
ns, non-significant; E, estrogen-treated group; EP, estrogen plus progesteronetreated group.
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5.

DISCUSSION

Graur et al. challenged the traditional taxonomy classifying guinea pigs in
Rodentia and proposed to consider guinea pigs as a separate mammalian order [101].
This proposal is based on protein sequence analysis and observations on many
physiological features of guinea pigs. Indeed, not only the evolution of genes
suggests that guinea pigs are different from rats, but also the physiology of guinea
pigs is very different from rats. A prolonged luteal phase with elevated progesterone
levels is present in humans, primates, and guinea pigs, but not in rats. In rats,
prolactin secretion is confounded by a circadian rhythm and estrogen alone can
initiate prolactin secretion [87]. Prolactin secretion in primates and guinea pigs, in
contrast, is stimulated by estrogen plus progesterone, but not by estrogen alone
[15,16]. This study showed that estrogen increased TPH enzyme in the raphe in
guinea pigs, in correlation with the finding that estrogen increases the TPH mRNA
levels in the raphe in monkeys. Moreover, in both guinea pigs and monkeys,
addition of progesterone to the estrogen treatment did not modify the effect of
estrogen. Thus, the result of this experiment supports the hypothesis that guinea
pigs are more like monkeys than they are like rats and that guinea pigs are a better
model than rats for the studies on the ovarian steroid regulation of serotonin and
prolactin.
Several lines of evidence support the hypothesis that progesterone stimulates
prolactin secretion via the serotonin neural systems [22-24]. Many pharmacological
studies have shown a stimulatory effect of serotonin on prolactin secretion in rodents
[23]. For example, the serotonin precursor, 5-hydroxytryptophan, alone or with
fluoxetine (a serotonin reuptake inhibitor) stimulated prolactin secretion [23].
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Serotonin receptor subtypes, serotonin 1, serotonin2, and serotonin3 are involved in
the regulation of prolactin [102]. 8-0H-DPAT, the serotonin1A receptor agonist,
increases serum prolactin [ 103-105]. In addition, PCPA, a serotonin synthesis
inhibitor, or ketanserin, a serotonin2 receptor antagonist reduces prolactin secretion
in pregnant rats [106]. Furthermore, the serotonergic system has been implicated in
regulating prolactin secretion in humans [107].
TPH is the rate-limiting enzyme for serotonin synthesis [41]. TPH mRNA
is increased by estrogen alone and progesterone has no effect on TPH gene
expression in monkeys [95]. However, serotonin levels in the guinea pig raphe were
increased by estrogen plus progesterone-treatment but not by estrogen alone [ 16].
Thus, there is a discrepancy between the effect of steroids on the gene expression of
the synthetic enzyme in monkeys and on the levels of the final serotonin product in
guinea pigs. I questioned whether the discrepancy came from a species difference
between guinea pigs and monkeys, or whether progesterone could act on posttranscriptional processes of TPH gene.
This study showed that, in OVX guinea pigs, estrogen treatment increased
TPH enzyme levels in the midbrain raphe and progesterone administration, in
addition to estrogen regimen, had no further effect. However, estrogen treatment did
not increase hypothalamic serotonin levels whereas progesterone with estrogen
increased serotonin levels in the hypothalamus. Thus, progesterone increased
serotonin levels without affecting the production of TPH enzyme. Although estrogen
stimulated TPH enzyme production, estrogen alone was insufficient to increase
serotonin levels. The steroid regulation of TPH protein in guinea pigs is consistent
with the steroid regulation of TPH mRNA in monkeys. Thus, the discrepancy
described above is not simply due to a species difference. Rather, there continues to
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be a discrepancy between the mass of the synthetic enzyme and the final transmitter
product in the same species, i.e., guinea pigs.
The observation that progesterone had no further effect on TPH enzyme ruled
out the possibility that progesterone regulates the post-transcriptional processing of
the TPH gene. Thus, the ability of progesterone to increase serotonin levels does not
occur by stimulation of TPH production. A tissue-specific translation efficiency has
been demonstrated in rats [97). The TPH mRNA level in the raphe is 150 times
lower than that in the pineal gland. Yet, TPH mRNA from one raphe yields
approximately the same amount of TPH protein as TPH mRNA from one pineal
gland does in vitro, suggesting the presence of different mechanisms regulating posttranscriptional events in the pineal and in the raphe. These mechanisms could be the
target for progesterone action. However, since ovarian steroids regulate the TPH
mRNA in monkeys and TPH protein in guinea pigs in the same manner, it is unlikely
that progesterone plays a role in the regulation of the translation efficiency of the
TPH gene in the raphe of female guinea pigs. TPH mRNA regulation by estrogen
and progesterone in guinea pigs needs to be examined to verify this speculation.
The finding that progesterone increased serotonin without affecting TPH
enzyme mass suggested that progesterone might affect the activity of the synthetic
enzyme for serotonin. The increase in the specific activity of TPH enzyme may
cause an increase in the production of serotonin. Progesterone could modify the
specific activity of TPH in a numbers of ways, such as regulating the
phosphorylation of the enzyme. Cyclic adenosine 3' ,5' -monophosphate (cAMP)dependent phosphorylation of the TPH is believed to be of functional significance for
the activation TPH enzyme [108,109). Protein kinase A increases the TPH activity
[110,111). Also, calmodulin-dependent protein kinase II is involved in the activation
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of TPH enzyme [112,113]. Recent reports indicate that 14-3-3 activator protein
family binds with phosphorylated-TPH and activates TPH [114,115]. Thus,
progesterone may stimulate the protein phosphorylation and activation systems to
increase TPH enzyme activity and the increased TPH activity results in an increase of
serotonin. Progesterone reduces the cAMP content in rat lungs [116]. However,
studies on reproductive tissues and pineal glands in rats have shown that
progesterone stimulates cAMP system [ 117, 118]. Furthermore, simultaneous
administration of estrogen and progesterone strongly activates cAMP-dependent
protein kinases in mammary tumor cells of mice [ 119]. The question of whether
progesterone may affect TPH activity via protein phosphorylation in the cytoplasm
remains to be answered.
Also in this experiment, the ratio of dopamine over the major metabolite of
dopamine, homovanillic acid, in the hypothalamus was increased significantly by
estrogen plus progesterone treatment, but not by estrogen alone. The increased
dopamine/homovanillic acid ratio caused by progesterone treatment indicates that
progesterone might decrease the activity of MAO in the hypothalamus. Since MAO
is the key metabolizing enzyme for both dopamine and serotonin, a decrease in the
activity of MAO will lead to an increase of serotonin. Supporting evidence for
progesterone to regulate MAO is from studies on human placental explants and
placental cells in culture [120,121]. In both cases, progesterone decreases MAO
activity. Studies in rats have also shown that estrogen decreases MAO activity in
regions in the hypothalamus [122]. Others in this lab recently measured serotonin
and 5-HIAA in monkey cerebrospinal fluid. They showed a significant decrease in
5-HIAA in estrogen plus progesterone-treated monkeys, indicating that progesterone
is very likely decreasing MAO. Hence, in addition to increasing the activity of TPH,
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decreasing the activity of MAO might be another mechanism by which progesterone
can increase serotonin levels in the raphe and hypothalamic terminal field.
Overall, there are multiple points in the functioning serotonergic system
which might be regulated by ovarian steroids, such as serotonin synthesis and
degradation, serotonin receptors, and serotonin reuptake. SERT is the transporter
protein responsible for serotonin reuptake. A decrease of the function of SERT will
increase the availability of serotonin. However, a recent finding in monkeys from
this laboratory indicates that progesterone does not decrease SERT mRNA levels in
the raphe nuclei [123], suggesting it is unlikely that progesterone increases serotonin
levels through regulating SERT at the level of gene expression. Again, however,
progesterone may be regulating the phosphorylation of SERT.
Serotonin receptors consist of diverse groups of subtypes and these different
subtypes can be stimulatory and inhibitory. Information about effects of
progesterone on the expression and function of these serotonin receptor subtypes is
limited to rats. Serotonin2 receptors are stimulatory, post-synaptic receptors which
act through the phosphoinositol pathway [81,82] whereas serotonin IA receptors may
be pre- or post-synaptic [83]. As autoreceptors, serotonin IA receptors inhibit the
activity of serotonin neurons. A recent report suggests that the serotonin IA
autoreceptor is related to the prevention of the calcium-calmodulin-dependent
activation of TPH [124]. In rats, prolonged treatment with estrogen or progesterone
induces a down regulation in serotonin I receptors, whereas the number of serotonin2
receptor goes up in female cortex [84,85]. Thus, progesterone may increase
prolactin secretion by increasing expression of serotonin2 receptors.
GABA neurons in the hypothalamus could also play an important role in
transducing the effect of progesterone and regulating prolactin secretion. GABA
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neurons contain progestin receptors [ 125] and GABA agonists increase prolactin
secretion in rodents [22]. GABA is an inhibitory transmitter. GABA neurons have
projections on tuberoinfindibular dopamine (TIDA) neurons [ 126, 127]. Thus,
GABA neurons could transduce the action of progesterone to TIDA neurons, which
in tum may affect the secretion of the lactotropes in the pituitary. Moreover, estrogen
rapidly attenuates a GABA receptor response in the MBH nuclei [128].
Unfortunately, the question of how progesterone can regulate functions of GABA
neurons has not been answered. Antagonist tests on GABA regulation of prolactin
secretion have not been done. In the search for the neural pathways which transduce
the effect of progesterone on prolactin secretion, the communication between neurons
in the hypothalamus and in the raphe needs to be further elaborated. Serotonin
neurons originating from the raphe synapse on progestin receptor-containing GABA
neurons[129]. PR-containing neurons in the ventrolateral hypothalamus, which are
implicated in the regulation of female sexual behavior of guinea pigs, project to the
raphe [129]. Agonists for GABA receptors increases serotonin levels in the raphe
[130]. Progestin receptor expression in neuroendocrine neurons in the hypothalamus
[ 131] and serotonin neurons in the raphe of monkeys [26] are induced by estrogen
and maintained in the presence of progesterone, consistent with the effect of
progesterone on prolactin secretion. However, the hierarchy and communication
between these neurons in regulating prolactin secretion needs to be clarified. The
question of whether serotonin, GABA, and other neural systems are conveying the
effect of progesterone in tum or whether they are exerting their effects on prolactin
secretion synergistically remains to be answered.
Serotonin has been correlated with depression. The condition of depressed
patients became worse following administration of the serotonin synthesis inhibitor
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PCPA [132]. Brain serotonin levels are, to some degree, dependent on plasma
tryptophan concentrations [133]. It has been shown that a severe depletion of plasma
tryptophan markedly alters the mood and behavior of patients [ 133]. In patients with
major depression, the serotonergic system may be dysfunctional. Prolactin has been
used as a marker for serotonin function in humans. Hence, prolactin release in
depressed patients is blunted during intravenous injection of tryptophan, compared to
the healthy controls [134]. Blunted prolactin responses to fenfluramine, a serotonin
releasing agent, has also been found in patients with mood disorders [135]. In
women with premenstrual syndromes, altered serotonergic activity has been
documented [136]. Furthermore, during chronic stress, anatomical adaptation has
been found in the serotonergic systems [137]. Meta-chlorophenylpiperazine, a
serotonin agonist can produce elevated mood in healthy volunteers [ 138]. Moreover,
the major antidepressants available today, including Prozac, are agents which can
increase 5 -HT levels in the synapse [139].
The observation that estrogen increased the TPH enzyme levels significantly
and the addition of progesterone had no further effect might provide a biological
basis for depression related to reproductive function in women. The withdrawal of
ovarian steroids has been correlated with mood disorders, such as premenstrual
syndrome, post-hysterectomy depression, postpartum depression, and postmenopausal depression [ 140, 141]. For example, irritablility, depression, and
emotional lability affect two-thirds of women in the first week postpartum [142].
Estrogen and progesterone fall abruptly on the first day of partum [143]. Hence,
there appears a correlation between the abrupt decline of steroid levels and
depression. Clinical studies show a moderate increase in estrogen levels can lead to a
pleasant feeling of well-being [144]. High dose of oral estrogen supplement
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effectively alleviates depression in patients who failed to respond to conventional
antidepressant treatment [ 144]. High progesterone levels during the menstrual cycle
are associated with relieving premenstrual syndrome and stabilizing mood as well
[145, 146].
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6.

CONCULUSIONS

The information available today indicates that estrogen plus progesterone
increases prolactin and serotonin in guinea pigs. This experiment demonstrated that
estrogen approximately doubled the TPH enzyme level in the raphe of ovariectomized
guinea pigs and supplemental progesterone had no additive effect. Estrogen plus
progesterone did increase serotonin levels in the hypothalamic terminal fields of
serotonin neurons, but estrogen alone did not show this effect. Thus, there
continues to be a discrepancy between the mass of the synthetic enzyme and the level
of the final serotonin product. A logical hypothesis is that progesterone might affect
the activity of TPH enzyme. The increase in the activity of TPH enzyme could lead
to the increase in serotonin level.
On the other hand, progesterone could decrease the degradation enzyme for
serotonin, MAO, to increase serotonin. The result from this experiment showed that
progesterone plus estrogen, but not estrogen alone, increased dopamine/homovanillic
acid ratio in the hypothalamus, suggesting that progesterone may regulate the activity
of MAO. The effects of progesterone on the gene expression, enzyme protein
production, and enzyme activity of MAO interesting areas for further study.
In summary, these results indicate that progesterone does not act at the level
of post-transcriptional processing of the TPH gene to increase serotonin or prolactin
levels. However, they do suggest an important mechanism by which ovarian
steroids can affect mood in women.
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